Neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease
(PD) present a major health burden to society. Changes in brain structure and cognition are …

Parkinsonian disorders are a heterogeneous group of incurable neurodegenerative
diseases that significantly reduce quality of life and constitute a substantial economic …

Objective measures of disease progression are critically needed in research on Parkinson's
disease (PD) and atypical Parkinsonism but may be hindered by both practicality and cost …

Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are characterized
by progressive white matter (WM) alterations associated with the prion-like spreading of four …

Background Non-motor symptoms (NMS) are compulsory clinical features for the clinical
diagnosis of multiple system atrophy (MSA), some of which precede motor symptoms onset …

Background Restricted repetitive behavior (RRB) is one of two behavioral domains required
for the diagnosis of autism spectrum disorder (ASD). Neuroimaging is widely used to study …

INTRODUCTION Magnetic resonance imaging (MRI) biomarkers are needed for indexing
early biological stages of Alzheimer's disease (AD), such as plasma amyloid‐β (Aβ42/40) …

Background Diffusion‐weighted magnetic resonance imaging (dMRI) examines tissue
microstructure integrity in vivo. Prior dementia with Lewy bodies (DLB) diffusion tensor …

Background It has been suggested that the loss of nigrostriatal dopaminergic axon terminals
occurs before the loss of dopaminergic neurons in the substantia nigra (SN) in Parkinson's …

It is established that one of the best predictors of a future diagnosis of Parkinson's disease is
a current diagnosis of rapid eye movement behaviour disorder (RBD). In such patients, this …